Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.34 USD | -3.25% | +15.37% | +63.18% |
02:00pm | Transcript : Agios Pharmaceuticals, Inc. - Special Call | |
12:56pm | Agios Pharmaceuticals' blood disorder drug succeeds in late-stage study | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+63.18% | 2.06B | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.09% | 21.96B | |
-9.84% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- AGIO Stock
- News Agios Pharmaceuticals, Inc.
- Agios Pharmaceuticals Says Phase 2 Trial of Mitapivat for Sickle Cell Disease Met Primary Endpoint